NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
19.53
-0.13 (-0.66%)
May 29, 2026, 4:00 PM EDT - Market closed
NRC Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 138.64 | 137.39 | 143.06 | 148.58 | 151.57 | 147.95 | |
Revenue Growth (YoY) | -1.88% | -3.96% | -3.72% | -1.97% | 2.44% | 11.01% |
Cost of Revenue | 52.96 | 52.37 | 56.93 | 56.02 | 57.05 | 52.35 |
Gross Profit | 85.68 | 85.02 | 86.13 | 92.57 | 94.52 | 95.6 |
Selling, General & Admin | 57.87 | 54.81 | 44.91 | 46.62 | 42.7 | 38.96 |
Depreciation & Amortization Expenses | 8.25 | 7.62 | 6.02 | 5.9 | 5.28 | 6.37 |
Total Operating Expenses | 66.12 | 62.43 | 50.93 | 52.52 | 47.98 | 45.33 |
Operating Income | 19.56 | 22.59 | 35.19 | 40.05 | 46.54 | 50.27 |
Interest Income | 0.13 | 0.11 | 0.13 | 0.82 | 0.17 | 0.01 |
Interest Expense | -5.12 | -4.76 | -2.6 | -0.86 | -1.21 | -1.67 |
Other Non-Operating Income (Expense) | -0.07 | -0.1 | -0.03 | -0.04 | -2.69 | 0 |
Total Non-Operating Income (Expense) | -5.06 | -4.75 | -2.5 | -0.08 | -3.73 | -1.65 |
Pretax Income | 14.5 | 17.85 | 32.69 | 39.96 | 42.82 | 48.62 |
Provision for Income Taxes | 5.47 | 6.25 | 7.91 | 8.99 | 11.02 | 11.16 |
Net Income | 9.04 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 |
Net Income to Common | 9.04 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 |
Net Income Growth | -62.68% | -53.19% | -19.98% | -2.61% | -15.12% | 0.55% |
Shares Outstanding (Basic) | 22 | 22 | 24 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 22 | 22 | 24 | 25 | 25 | 26 |
Shares Change (YoY) | -5.85% | -5.67% | -3.77% | -1.51% | -2.29% | -0.22% |
EPS (Basic) | 0.39 | 0.50 | 1.05 | 1.26 | 1.28 | 1.47 |
EPS (Diluted) | 0.39 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 |
EPS Growth | -62.14% | -51.92% | -16.80% | -1.57% | -13.01% | 0.69% |
Shares Outstanding | 22.54 | 22.64 | 23.08 | 24.22 | 24.63 | 25.36 |
Free Cash Flow | 17.43 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 |
Free Cash Flow Growth | 10.71% | -17.90% | -14.13% | -15.50% | -35.27% | 11.40% |
Free Cash Flow Per Share | 0.79 | 0.70 | 0.81 | 0.91 | 1.06 | 1.59 |
Dividends Per Share | 0.560 | 0.520 | 0.480 | 0.480 | 0.840 | 0.480 |
Dividend Growth | 7.69% | 8.33% | - | -42.86% | 75.00% | 128.57% |
Gross Margin | 61.80% | 61.88% | 60.20% | 62.30% | 62.36% | 64.62% |
Operating Margin | 14.11% | 16.44% | 24.60% | 26.95% | 30.71% | 33.98% |
Profit Margin | 6.52% | 8.44% | 17.32% | 20.84% | 20.98% | 25.32% |
FCF Margin | 12.57% | 11.46% | 13.40% | 15.03% | 17.44% | 27.60% |
EBITDA | 27.82 | 30.21 | 41.22 | 45.94 | 51.82 | 56.64 |
EBITDA Margin | 20.06% | 21.99% | 28.81% | 30.92% | 34.19% | 38.28% |
EBIT | 19.56 | 22.59 | 35.19 | 40.05 | 46.54 | 50.27 |
EBIT Margin | 14.11% | 16.44% | 24.60% | 26.95% | 30.71% | 33.98% |
Effective Tax Rate | 37.69% | 35.00% | 24.19% | 22.50% | 25.73% | 22.94% |